Rigorously tested and continuously validated in practice, Cytel software is used at thousands of pharmaceutical, biotech, medical device companies, and leading independent research institutes.
Cytel’s cutting-edge trial design and implementation expertise, with a specialty in adaptive trials, is helping sponsor companies of all sizes to increase success rates in clinical development.
New Software Revealed
Cytel Co-Founder and CTO Nitin Patel reveals new simulation and modeling software for better development decision-making.
Just Published in Nature Journal
Cyrus Mehta, Cytel president and co-founder, co-authored new paper on emerging Efficacy-to-Effectiveness trials in Nature's Clinical Pharmacology & Therapeutics.
CMO Dr. Adam Craig on aligning the medical and financial rationales in an adaptive sample size re-estimation oncology trial.